Enterprise Europe Network

Russian developer of intelligent software is looking for licensees

Country of origin:
Country: 
RUSSIA
Opportunity:
External Id: 
BORU20200113020
Published
17/01/2020
Last update
13/02/2020
Expiration date
13/02/2021

Keywords

Partner keyword: 
Artificial Intelligence (AI)
Artificial intelligence related software
Other software publishing
Other information technology and computer service activities
EXPRESS YOUR INTEREST

Summary

Summary: 
A Russian company developed intelligent software by processing experimental, genomic, expression and other biological data. The company is looking for new customers and partners to conclude long-term license agreements.

Description

Description: 

The Russian company from the city of Novosibirsk was founded in 2004. The company is a center of competence in information technology, bioinformatics, and machine learning. The company provides services to innovative companies and solves high-tech tasks in the data processing. The creation of such complex software systems helps solve problems that lie at the intersection of disciplines such as biology, mathematics, and information technology.
The company offers useful software in the field of bioinformatics which allows the machine to be trained to find important patterns in huge tables of biological parameters. After verification they can be used for diagnostics, prescribing drugs or planning experiments. Bio information technologies allow developing individual treatment methods and diagnostic tools and testing drugs on cell lines of patients who are not at risk of side effects from the patients themselves.
The software applies to pharmaceutical companies, software developers for big data processing, research laboratories, diagnostic centers, and biobanks. The company consists of more than highly qualified specialists, mathematicians, bioinformatics and biologists as well as consultants and consultants in narrow areas including medical doctors.
The Russian company is looking for foreign partners from various industries (medicine, biochemistry, electronics, physics, etc.) to conclude a long-term license agreement. Under the license agreement, the Russian company will provide exclusive rights to use the result of intellectual activity for foreign partners and also be responsible for the financial effectiveness of the invention under the contract. The Russian company wants to cooperate with foreign partners to deepen joint development, introduce new technologies and exchange experience, as well as to further distribute its products under a license agreement. Foreign companies will be required to provide reports on the use of the intelligent software of a Russian company.

Advantages & innovations

Cooperation plus value: 
• Extracting knowledge from omics data allows clinics and other medical institutions to clarify the diagnosis and prescribe more effective treatment • With the help of bio-information technologies, each person can find out a predisposition to certain diseases, plan a family and study his pedigree. • Development and application of artificial intelligence methods allow using a neural network to teach a computer to recognize speech or "read" handwritten texts. • Ideas and developments in the field of healthcare allow using information technologies to introduce new ways of combating diseases

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
Type - industrial companies related to biotechnology, companies involved in electronics, companies in the field of medicine Role - a foreign partner will buy the intelligent software of a Russian company to obtain new technological capabilities and their operation in accordance with a license agreement

Type and size

Cooperation task: 
SME 11-50,SME <10,251-500,SME 51-250,>500